SYM FINANCIAL Corp Has $330,000 Stock Holdings in Cigna Group $CI

SYM FINANCIAL Corp lifted its holdings in Cigna Group (NYSE:CI) by 21.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 998 shares of the health services provider’s stock after buying an additional 179 shares during the period. SYM FINANCIAL Corp’s holdings in Cigna Group were worth $330,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of CI. Brighton Jones LLC boosted its position in shares of Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after buying an additional 318 shares during the period. Mirae Asset Global Investments Co. Ltd. grew its stake in Cigna Group by 6.2% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 36,888 shares of the health services provider’s stock valued at $11,990,000 after purchasing an additional 2,143 shares in the last quarter. Sunbelt Securities Inc. increased its position in Cigna Group by 27.6% in the 1st quarter. Sunbelt Securities Inc. now owns 222 shares of the health services provider’s stock worth $73,000 after purchasing an additional 48 shares during the last quarter. Sovran Advisors LLC acquired a new position in shares of Cigna Group during the 1st quarter valued at about $214,000. Finally, Avidian Wealth Enterprises LLC increased its holdings in shares of Cigna Group by 5.1% during the 1st quarter. Avidian Wealth Enterprises LLC now owns 3,821 shares of the health services provider’s stock valued at $1,257,000 after acquiring an additional 184 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insiders Place Their Bets

In other news, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the sale, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Nicole S. Jones sold 28,526 shares of the company’s stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares in the company, valued at $7,694,400. This trade represents a 52.66% decrease in their position. The disclosure for this sale can be found here. 0.70% of the stock is currently owned by company insiders.

Cigna Group Trading Up 2.6%

Shares of CI opened at $309.61 on Tuesday. The stock has a fifty day moving average price of $299.43 and a two-hundred day moving average price of $307.46. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. Cigna Group has a 52-week low of $256.89 and a 52-week high of $350.00. The company has a market cap of $82.64 billion, a price-to-earnings ratio of 16.90, a PEG ratio of 0.88 and a beta of 0.45.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. During the same quarter in the previous year, the company posted $6.72 EPS. The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be given a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date is Thursday, December 4th. Cigna Group’s dividend payout ratio (DPR) is presently 32.97%.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Barclays increased their price objective on Cigna Group from $354.00 to $383.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. Wall Street Zen lowered Cigna Group from a “buy” rating to a “hold” rating in a report on Friday, October 3rd. Robert W. Baird set a $372.00 target price on Cigna Group in a report on Thursday, August 14th. Guggenheim reaffirmed a “buy” rating and issued a $350.00 target price (down previously from $388.00) on shares of Cigna Group in a report on Monday, August 4th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $365.00 target price on shares of Cigna Group in a report on Tuesday, August 26th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $369.89.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.